AXGN
Price
$55.75Alerts
Change
-$0.60 (-1.06%)
Updated
Nov 20 closing price
Capitalization
2.93B
93 days until earnings call
Intraday BUY SELL Signals
ICUI
Price
$172.52Alerts
Change
-$3.24 (-1.84%)
Updated
Nov 20 closing price
Capitalization
4.3B
101 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AXGN vs ICUI

AXGN vs ICUI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AXGN vs. ICUI commentary
Nov 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXGN is a Hold and ICUI is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AXGN with price predictions
Nov 20, 2026

AXGN's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for AXGN turned positive on October 20, 2026. Looking at past instances where AXGN's MACD turned positive, the stock continued to rise in 43 of 47 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on AXGN as a result. In 66 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.

AXGN moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AXGN crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.

Following a +15.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXGN advanced for three days, in 266 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

The Aroon Indicator entered an Uptrend today. In 224 of 264 cases where AXGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.

Bearish Trend Analysis

The 10-day RSI Indicator for AXGN moved out of overbought territory on November 19, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In 34 of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at 79%.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

AXGN broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.452) is normal, around the industry mean (4.142). P/E Ratio (-74.657) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.080) settles around the average of (0.011) among similar stocks. P/S Ratio (8.961) is also within normal values, averaging (40.124).

The Tickeron Profit vs. Risk Rating rating for this company is 10 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. AXGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 79 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for ICUI with price predictions
Nov 20, 2026

ICUI sees MACD Histogram just turned negative

ICUI saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 20, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 50 instances where the indicator turned negative. In 37 of the 50 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ICUI moved out of overbought territory on November 11, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 19 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 70%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 60 cases where ICUI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 68%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICUI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

ICUI broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on ICUI as a result. In 67 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.

ICUI moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ICUI crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 77%.

Following a +2.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICUI advanced for three days, in 190 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

The Aroon Indicator entered an Uptrend today. In 157 of 207 cases where ICUI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 76%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. ICUI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.000) is normal, around the industry mean (4.964). ICUI has a moderately high P/E Ratio (143.425) as compared to the industry average of (40.591). Projected Growth (PEG Ratio) (0.081) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.006) among similar stocks. P/S Ratio (1.808) is also within normal values, averaging (56.876).

The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICUI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
AXGN vs ICUI: Fundamental Ratings
AXGN
ICUI
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
87
Overvalued
PROFIT vs RISK RATING
1..100
10100
SMR RATING
1..100
9589
PRICE GROWTH RATING
1..100
3440
P/E GROWTH RATING
1..100
7997
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AXGN's Valuation (4) in the Medical Specialties industry is significantly better than the same rating for ICUI (87). This means that AXGN’s stock grew significantly faster than ICUI’s over the last 12 months.

AXGN's Profit vs Risk Rating (10) in the Medical Specialties industry is significantly better than the same rating for ICUI (100). This means that AXGN’s stock grew significantly faster than ICUI’s over the last 12 months.

ICUI's SMR Rating (89) in the Medical Specialties industry is in the same range as AXGN (95). This means that ICUI’s stock grew similarly to AXGN’s over the last 12 months.

AXGN's Price Growth Rating (34) in the Medical Specialties industry is in the same range as ICUI (40). This means that AXGN’s stock grew similarly to ICUI’s over the last 12 months.

AXGN's P/E Growth Rating (79) in the Medical Specialties industry is in the same range as ICUI (97). This means that AXGN’s stock grew similarly to ICUI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXGNICUI
RSI
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
68%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
72%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
73%
Advances
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 7 days ago
69%
Declines
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
72%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
76%
COMPARISON
Comparison
Nov 22, 2026
Stock price -- (AXGN: $55.75 vs. ICUI: $172.52)
Brand notoriety: AXGN and ICUI are both not notable
AXGN represents the Medical/Nursing Services, while ICUI is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AXGN: 51% vs. ICUI: 93%
Market capitalization -- AXGN: $2.93B vs. ICUI: $4.3B
AXGN [@Medical/Nursing Services] is valued at $2.93B. ICUI’s [@Pharmaceuticals: Other] market capitalization is $4.3B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $159.96B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXGN’s FA Score shows that 2 FA rating(s) are green while ICUI’s FA Score has 0 green FA rating(s).

  • AXGN’s FA Score: 2 green, 3 red.
  • ICUI’s FA Score: 0 green, 5 red.
According to our system of comparison, AXGN is a better buy in the long-term than ICUI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXGN’s TA Score shows that 6 TA indicator(s) are bullish while ICUI’s TA Score has 5 bullish TA indicator(s).

  • AXGN’s TA Score: 6 bullish, 4 bearish.
  • ICUI’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AXGN is a better buy in the short-term than ICUI.

Price Growth

AXGN (@Medical/Nursing Services) experienced а -0.32% price change this week, while ICUI (@Pharmaceuticals: Other) price change was -3.77% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -11.44%. For the same industry, the average monthly price growth was -15.18%, and the average quarterly price growth was -18.29%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -7.82%. For the same industry, the average monthly price growth was -5.08%, and the average quarterly price growth was +4.34%.

Reported Earning Dates

AXGN is expected to report earnings on Feb 23, 2027.

ICUI is expected to report earnings on Mar 03, 2027.

Industries' Descriptions

@Medical/Nursing Services (-11.44% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-7.82% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
Interact to see
Advertisement

ICUI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with CLPT. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then CLPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICUI
1D Price
Change %
ICUI100%
-1.84%
CLPT - ICUI
57%
Loosely correlated
-5.47%
ALGN - ICUI
55%
Loosely correlated
-2.82%
MMSI - ICUI
53%
Loosely correlated
-0.08%
A - ICUI
50%
Loosely correlated
-2.83%
COO - ICUI
49%
Loosely correlated
-2.40%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MSTZ8.091.27
+18.62%
T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ)
GMOC50.200.03
+0.05%
GMO Ultra-Short Income ETF (GMOC)
EVN9.14-0.01
-0.11%
Eaton Vance Municipal Income Trust
HDEF32.82-0.28
-0.85%
Xtrackers MSCI EAFE High Dividend Yield Equity ETF (HDEF)
FPSX0.69-0.27
-28.14%
Leverage Shares 2X Long FPS Daily ETF (FPSX)